Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) 3-Year EBITDA Growth Rate : 8.60% (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Jingxin Pharmaceutical Co 3-Year EBITDA Growth Rate?

Zhejiang Jingxin Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.24.

During the past 12 months, Zhejiang Jingxin Pharmaceutical Co's average EBITDA Per Share Growth Rate was 15.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 8.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zhejiang Jingxin Pharmaceutical Co was 33.80% per year. The lowest was -15.40% per year. And the median was 12.15% per year.

Competitive Comparison of Zhejiang Jingxin Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jingxin Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Jingxin Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jingxin Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Jingxin Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Zhejiang Jingxin Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Zhejiang Jingxin Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Jingxin Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jingxin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jingxin Pharmaceutical Co Ltd (SZSE:002020) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No.800 Xinchang East Road, Yulin subdistrict, Zhejiang Province, Xinchang, CHN, 312500

Website

http://www.jingxinpharm.com

Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.

Executives

Wang Neng Neng	Director
Chen Shao Bi	Executives
Wang Guang Qiang	Supervisors
Lv Gang	Director
Zhou Lin	Executives
Yu Yi Ping	Supervisors
Chen Mei Li	Directors, executives
Zhang Li Wa	Directors, executives
Wu Zheng Jie	Director

Zhejiang Jingxin Pharmaceutical Co Headlines

No Headlines